Founded in Quebec City in 2015, diaMentis is the first company to develop a software as medical device (SaMD) that analyses information from a simple examination of the eye (electroretinography).
Mission: Develop, valorise, patent and market (directly or indirectly) a diagnostic tool for better management of patients with mental disorders in a personalised healthcare environment.
diaMentis value proposition:
• A non-invasive, not expensive and easy to implement test
• A reliable method of analysis
• Fast results via a centralized service
diaMentis technology will lead to:
• More accurate and faster diagnosis
• Appropriate choice of treatments and psychotherapy
• Better acceptance of the disease by the patient and better monitoring of treatments
• Reduction in relapses
• Decrease in duration and number of hospitalizations
• Return to work faster (reduction of disability premiums and family pressure)
Company Details
- Employees
- 15
- Founded
- -
- Address
- 2875 Boulevard Laurier, Suite D1-1100,canada
- Phone
- +1 418 380-5757
- Industry
- Biotechnology
- Website
- diamentis.com
- Keywords
- Santé mentale, Biotechnologie, Psychiatrie, Innovation, Software as a Medical Device, Électrorétinographie, Médecine personnalisée, Schizophrénie, Bipolarité, Dépression majeure, Anxiété, Mental health, Biotechnology, Psychiatry, Electroretinography, Personalized medicine, Schizophrenia, Bipolarity, Major depression, Anxiety.
- HQ
- Québec, Québec
Diamentis Questions
Diamentis's helpline number is +1 418 380-5757
Diamentis's website is diamentis.com
Diamentis's LinkedIn profile is https://ca.linkedin.com/company/diamentisinc
Diamentis has
15 employees.
View email and phone details for 15
employees at Diamentis.
Diamentis's industry is
Biotechnology
Diamentis's top competitors are
Norda Stelo,
Silicycle,
Ebovir Biotechnologie Inc.,
Eye Disease Foundation,
Renard Blanc,
3dexperience Lab,
O2 Commerce,
Enduride Inc.,
Cervo Brain Research Centre,
Culligan Québec.
Diamentis's categories are Biotechnology
Diamentis's founding year is 2015
